|
1.
|
2023/12/21
|
|
Preoperative suspicion of parathyroid carcinoma based on clinical findings
in a patient with primary hyperparathyroidism
|
|
2.
|
2023/02
|
|
Longitudinal change of postoperative serum anti-thyroglobulin antibody levels in patients without total thyroidectomy and remnant ablation
|
|
3.
|
2021/04
|
|
A Case of Takotsubo syndrome after Surgery for Papillary Thyroid Cancer.
|
|
4.
|
2021/04
|
|
A giant axillary mass treated as breast cancer metastasis.
|
|
5.
|
2018/04
|
|
Expression of Leptin and Leptin Receptor Messenger Ribonucleic Acids in Thyroid Carcinoma
|
|
6.
|
2017/06
|
|
Anti-cancer stem cell activity of the Src inhibitor dasatinib in thyroid cancer cells.
|
|
7.
|
2014/09
|
|
A case of adenomatous goiter involving diffuse, acute, and painful thyroid enlargement after fine-needle aspiration cytology.
|
|
8.
|
2013/09
|
|
Biological Characteristics and Treatment Strategy of Anaplastic Thyroid Carcinoma
|
|
9.
|
2012/06
|
|
Current trends in TSH suppression therapy for patients with papillary thyroid carcinoma in Japan: results of a questionnaire distributed to councilors of the Japanese Society of Thyroid Surgery.
|
|
10.
|
2011/04
|
|
Analysis of clinical outcome of patients with poorly differentiated thyroid carcinoma.
|
|
11.
|
2010/01
|
|
Preoperative dynamic lymphoscintigraphy predicts sentinel lymph node metastasis in patients with early breast cancer.
|
|
12.
|
2009/05
|
|
A Case of Euthyroid Graves Disease Which Developed Into Graves Disease With Thyrotoxicosis After Subacute Thyroiditis
|
|
13.
|
2009/01
|
|
The expression of monocyte chemotactic protein-1 in papillary thyroid carcinoma is correlated with lymph node metastasis and tumor recurrence.
|
|
14.
|
2007/04
|
|
The relationship between Wilms' tumor 1 (WT1) and paired box 8 (Pax-8) protein expressions in papillary and anaplastic thyroid carcinomas.
|
|
15.
|
2006/10
|
|
Additive antitumor effects of gefitinib and imatinib on anaplastic thyroid cancer cells.
|
|
16.
|
2006/04
|
|
Macrognathia secondary to dialysis-related renal osteodystrophy treated successfully by parathyroidectomy.
|
|
17.
|
2006/03
|
|
Combined measurement of serum sialyl Lewis X with serum CA 15-3 in breast cancer patients.
|
|
18.
|
2006/01
|
|
Loss of BRCA1 expression may predict shorter time-to-progression in metastatic breast cancer patients treated with taxanes.
|
|
19.
|
2005/09
|
|
Retrospective analysis of predictive factors for recurrence after curatively resected papillary thyroid carcinoma.
|
|
20.
|
2004/11
|
|
Significance of Serum Tumor Markers in Monitoring Advanced Breast Cancer Patients Treated with Systemic Therapy: A Prospective Study.
|
|
21.
|
2004/01
|
|
Additive antitumour effect of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (Iressa, ZD1839) and the antioestrogen fulvestrant (Faslodex, ICI 182, 780) in breast cancer cells.
|
|
22.
|
2004
|
|
Guest Review: Angiogenesis in thyroid cancer.
|
|
23.
|
2003/12
|
|
Technetium-99m methoxyisobutyl isonitrile scintigrapfhy of bone metastasis in three patients with differentiated thyroid cancer.
|
|
24.
|
2003/10
|
|
Metastatic papillary thyroid carcinoma of the submandibular lymph nodes with extensive squamous metaplasia: Report of a case.
|
|
25.
|
2003/07
|
|
Measuring quality of life in patients with breast cancer: a systematic review of reliable and valid instruments available in Japan.
|
|
26.
|
2003/03
|
|
Medroxyprogesterone acetate decreases secretion of interleukin-6 and parathyroid hormone-related protein in a new anaplastic thyroid cancer cell line, KTC-2.
|
|
27.
|
2003/01
|
|
Significance of serum carcinoembryonic antigen and CA 15-3 in monitoring advanced breast cancer patients treated with systemic therapy: a large-scale retrospective study.
|
|
28.
|
2002/09
|
|
Expression of vascular endothelial growth factor family messenger RNA in diseased thyroid tissues.
|
|
29.
|
2002/05
|
|
Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma.
|
|
30.
|
2001/06
|
|
Differentiation markers in papillary thyroid carcinoma.
|
|
31.
|
2000/10
|
|
Changes of expression level of the differentiation markers in papillary thyroid carcinoma under thyrotropin suppression therapy in vivo immunohistochemical detection of thyroglobulin, thyroid peroxidase, and thyrotropin receptor
|
|
32.
|
2000/08
|
|
All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1.
|
|
33.
|
2000/04
|
|
Semi-quantitative comparison of the differentiation markers and sodium iodide symporter messenger ribonucleic acids in papillary thyroid carcinomas using RT-PCR.
|
|
34.
|
2000/02
|
|
Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.
|
|
35.
|
2000/01
|
|
Anti-HER2 antibody enhances the growth inhibitory effect of anti-oestrogen on breast cancer cells expressing both oestrogen receptors and HER2.
|
|
36.
|
1999/10
|
|
Analyses of the outcome of locally invasive papillary thyroid carcinomas.
|
|
37.
|
1999/09
|
|
Expression of vascular endothelial growth factor (VEGF) family members in breast cancer.
|
|
38.
|
1999/02
|
|
Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6.
|
|
39.
|
1999/01
|
|
Biochemical markers of bone turnover in breast cancer patients with bone metastases: a preliminary report.
|
|
40.
|
1997
|
|
Relationship between prognostic score and thyrotropin receptor(TSH-R) in papillary thyroid carcinoma : immunohistochemical detection of TSH-R
|
|
41.
|
1996/03
|
|
Heterogeneous distribution of thyrotropin receptor messenger ribonucleic acid (TSH-R mRNA) in papillary thyroid carcinomas detected by in situ hybridization
|
|
Display 5 items
|
|
Display all(41)
|
